Skip to main
University-wide Navigation

UK Researcher Named AAAS Science & Technology Policy Fellow

AAAS fellows serve yearlong assignments in the federal government. Larian will be placed at the Center for Nutrition in the United States Agency for International Development (USAID) Bureau of Resilience and Food Security in Washington D.C.

UK Research Center Establishes Scholar Program to Promote Diversity in Neurotrauma Studies

Prendergast says statistics show that less than five percent of undergraduate neuroscience students in the U.S. are Black or African American, but at UK nearly ten percent of undergraduate neuroscience majors identify as Black or African American.

UK Virologist Shares What We Know About COVID-19

Dutch is leading the College of Medicine’s COVID-19 Unified Research Experts (CURE) Alliance team, which brings together faculty expertise from multiple disciplines across the university to focus on advising COVID-19 patient care and clinical trials based on emerging research.

UK Receives $3.2 Million for Traumatic Brain Injury Research

The National Institutes of Health award will fund ongoing research led by UK Neuroscience and Spinal Cord and Brain Injury Research Center (SCoBIRC) Professor Patrick Sullivan, Ph.D., who has studied the effects of the experimental drug MP201 on TBI.

UK Center for Health Equity Transformation Awards 3 Pilot Research Grants

“The significance of addressing health and other inequities has never been greater,” said Nancy Schoenberg, CHET director. “While we received numerous rigorous proposals, these projects stood out for their capacity to employ stellar research approaches to make impactful change."

UK Research Could Pave Way for Noonan-like Syndrome Treatment

Emilia Galperin, a Kentucky College of Medicine researcher, has been awarded $1.9 million to continue research examining molecular pathogenesis of Noonan-like syndrome.

Orthopaedic Trauma Research Fellowship Offers Second Chance for Medical Students

The program is for those who don’t receive a match to receive mentorship and experience to improve their resumé. UK’s program is one year, which gives fellows the time to reapply for residency programs by the next Match Day.

Artemisia Annua Could Be Promising Treatment for COVID-19

The new potential treatment has been added to the University of Kentucky’s innovative clinical trial for experimental COVID-19 therapies, which was launched by leaders from UK’s Markey Cancer Center, College of Medicine and College of Pharmacy in May.

UK's Korotkov Partners With Atomwise to Screen for Potential Drugs Against Novel COVID-19 Target

UK announced a research collaboration with Atomwise, an industry leader in using artificial intelligence (AI) for small molecule discovery, to explore potential COVID-19 therapies.

Alpacas Could be the Secret Weapon Against COVID-19

UK College of Medicine researchers are using the special antibodies made by alpacas, called nanobodies, to help understand the novel coronavirus and potentially develop a treatment that could protect people from being infected.